NCT02805049View on ClinicalTrials.gov

Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 28, 2017

Primary Completion Date

June 23, 2018

Study Completion Date

June 23, 2018

Conditions
Septic ShockPeritonitis
Interventions
DRUG

Echinocandins

The patients included in this protocol require routine treatment with caspofungin or micafungin. Though this intervention is under study, it is not modified by this protocol.

Trial Locations (2)

4029

Royal Brisbane Women's Hospital, Herston

30029

CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT02805049 - Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis | Biotech Hunter | Biotech Hunter